Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main Eagle Pharmaceuticals, Inc. Transaction History

Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main

$94.9 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2024	SELL	$25.06 - $34.09 $1.6 Million - $2.17 Million	-63,668 Reduced 27.7%	166,203 $4.72 Million
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $1.6 Million - $2.17 Million	-63,668 Reduced 27.7%	166,203 $4.72 Million
Q4 2022 May 17, 2024	BUY	$24.98 - $39.77 $5.74 Million - $9.14 Million	229,871 New	229,871 $6.72 Million
Q4 2022 Feb 14, 2023	SELL	$24.98 - $39.77 $1.39 Million - $2.22 Million	-55,740 Reduced 19.52%	229,871 $6.72 Million
Q3 2022 Nov 14, 2022	SELL	$26.42 - $47.12 $221,478 - $395,006	-8,383 Reduced 2.85%	285,611 $7.55 Million
Q2 2022 Aug 15, 2022	BUY	$41.26 - $51.35 $5.07 Million - $6.31 Million	122,898 Added 71.83%	293,994 $13.1 Million
Q1 2022 May 16, 2022	BUY	$44.58 - $52.6 $7.39 Million - $8.72 Million	165,770 Added 3112.47%	171,096 $8.47 Million
Q3 2021 Nov 15, 2021	BUY	$43.79 - $55.78 $233,225 - $297,084	5,326 New	5,326 $297,000
Q2 2020 Aug 14, 2020	SELL	$43.24 - $55.02 $188,180 - $239,447	-4,352 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$34.37 - $60.07 $34,473 - $60,250	1,003 Added 29.95%	4,352 $200,000
Q4 2019 Feb 14, 2020	SELL	$54.32 - $64.31 $54,482 - $64,502	-1,003 Reduced 23.05%	3,349 $201,000
Q3 2019 Nov 14, 2019	SELL	$53.25 - $59.98 $5.26 Million - $5.92 Million	-98,716 Reduced 95.78%	4,352 $246,000
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $117,923 - $147,878	-2,530 Reduced 2.4%	103,068 $5.74 Million
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $237,372 - $318,174	6,140 Added 6.17%	105,598 $5.33 Million
Q4 2018 Feb 14, 2019	SELL	$36.72 - $67.73 $495,683 - $914,287	-13,499 Reduced 11.95%	99,458 $3.9 Million
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $631,642 - $794,741	-9,477 Reduced 7.74%	112,957 $0
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $26,701 - $39,919	521 Added 0.43%	122,434 $9.26 Million
Q1 2018 May 15, 2018	BUY	$52.16 - $66.86 $1.52 Million - $1.95 Million	29,166 Added 31.45%	121,913 $6.42 Million
Q4 2017 Feb 14, 2018	BUY	$49.6 - $60.87 $153,065 - $187,844	3,086 Added 3.44%	92,747 $4.95 Million
Q3 2017 Nov 14, 2017	BUY	$46.62 - $60.36 $4.18 Million - $5.41 Million	89,661	89,661 $5.35 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main, based on Form 13F filings with the SEC.

News

Stay updated on Dz Bank Ag Deutsche Zentral Genossenschafts Bank, Frankfurt Am Main with notifications on news.

Account